No Data
No Data
BUYSELL, P anti-aging
"UBS" <7685> BUYSELL NEUTRAL → BUY upgrade "Daiwa" <4934> P Anti-Age 3 unchanged * The ratings of the above companies are confirmed by us as of 10/04.
Izutsuya and other [buying demand for next week]
[Buy Demand for Next Week (Table)] Code; Brand; Stock Price Impact; Buying Demand; Margin Ratio; Closing Price; Day-on-Day Change <7872>; Estelle; 390%; 18,700; 0.60; 627; 3 <7510>; Takebishi; 314%; 113,000; 0.01; 2,381; 34 <4934>; P Anti-Age; 303%; 27,300; 1.89; 726; -9 <5031>; Moi; 292%; 61,300; 2.16; 266; -4 <5262>; Nihume;
The TOPIX Global Market 250 index fell, with the recoil of the previous day's sharp rise before the three-day weekend.
Tokyo Stock Exchange Growth Market Index 823.52 -10.21 / Volume 0.17 billion 70.09 million shares / Trading value 116.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 644.48 -8.79 / Volume 0.19 billion 9.93 million shares / Trading value 95.9 billion yen. The growth market today, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, fell. The number of advancing stocks is 197, the number of declining stocks is 352, and unchanged is 30. The US stock market continued to rise on the 12th. The Dow Jones Industrial Average was up 235.06 points (+0
Premier Anti-Aging to Propose Stock Options for Directors; Shares Down 12%
Tobu Construction Corp. 1Q operating profit increased by 72.5% to 5.168 billion yen.
The construction corporation <1766> announced its performance for the first quarter of the fiscal year ending in April 2025, with revenue increasing by 8.3% year-on-year to 89.012 billion yen, and operating profit increasing by 72.5% to 5.168 billion yen. In the real estate rental business, revenue increased compared to the same period last year due to the increase in the number of managed properties and the increase in rental and management fee income from tenants through the sublease management system (bulk lease system). In the construction business, the increase in the order backlog in the previous consolidated fiscal year.
Premier Anti-Aging Co. Faces Sales Decline but Maintains Solid Equity
No Data
No Data